sweet kakoii - saved me finding it
So.... they have the IP - worth knowing because Cellspray in terms of product is the rain maker.
ReCell is limited to 2% of the patient's body surface area - so it is for just minor and usually cosmetic surgery.
Cellspray is for up to 90% of the body whilst CellsprayXP is much quicker but covers 30%
Interesting that I scoured every AVH report and never found that 2% max body area anywhere.
Referring to CCE's presentaion:http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=00448809
The applicable global market for ReCell is $1.7billion dollars whilst the Cellspray market is $5billlion
sweet kakoii - saved me finding itSo.... they have the IP -...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.73 |
Change
-0.200(6.83%) |
Mkt cap ! $185.9M | |||
| Open | High | Low | Value | Volume |
| $2.70 | $2.77 | $2.63 | $1.420M | 521.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3075 | $2.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.73 | 45063 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |